• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白A-I芬兰型。由于载脂蛋白A-I基因中的单个碱基替换导致的显性遗传性低α脂蛋白血症。

Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene.

作者信息

Miettinen H E, Gylling H, Miettinen T A, Viikari J, Paulin L, Kontula K

机构信息

Institute of Biotechnology, University of Helsinki, Finland.

出版信息

Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):83-90. doi: 10.1161/01.atv.17.1.83.

DOI:10.1161/01.atv.17.1.83
PMID:9012641
Abstract

We have identified a large kindred with severe serum HDL cholesterol deficiency. The proband, a 65-year-old woman, had greatly diminished concentrations of serum HDL cholesterol (0.19 mmol/L) and apolipoprotein (apo) A-I (21.9 mg/dL). HDL cholesterol and apo A-I levels were similarly reduced in all affected family members, while apo A-II levels were about half of those in the nonaffected family members. Pedigree analysis suggested a dominant inheritance pattern of the phenotype. Sequence analysis of the exons and exon-intron boundaries of the apo A-I gene revealed heterozygosity for a single T-to-G point mutation substituting arginine for leucine at residue 159 of the mature apo A-I protein (apo A-IFin). The T-to-G substitution destroys an Fsp I cleavage site, permitting direct polymerase chain reaction/restriction enzyme analysis of the mutation. All the affected family members were shown to be heterozygous for the apo A-IFin mutation. Isoelectric focusing revealed the presence of the mutant apo A-IFin protein in both serum and HDL of the affected subjects. Functional consequences of the mutation were examined by expressing the mutated and wild-type apo A-I cDNAs in COS-7 cells. The mutant apo A-I mRNA had a size similar to that of the normal mRNA, and both mutant and wild-type apo A-I proteins were secreted into the cell media. In vivo kinetic studies of apo A-I revealed increased catabolism in affected subjects. In conclusion, we describe a novel point mutation of the apo A-I gene, apo A-IFin, causing a dominantly negative phenotype as regards serum HDL levels, possibly due to increased catabolism of apo A-I.

摘要

我们鉴定出一个患有严重血清高密度脂蛋白(HDL)胆固醇缺乏症的大家族。先证者是一名65岁女性,其血清HDL胆固醇浓度(0.19 mmol/L)和载脂蛋白(apo)A-I(21.9 mg/dL)大幅降低。所有受影响家庭成员的HDL胆固醇和apo A-I水平均同样降低,而apo A-II水平约为未受影响家庭成员的一半。系谱分析表明该表型呈显性遗传模式。对apo A-I基因的外显子和外显子-内含子边界进行序列分析,发现成熟apo A-I蛋白(apo A-IFin)第159位残基处发生单个T到G的点突变,导致精氨酸替代亮氨酸,呈现杂合状态。T到G的替换破坏了一个Fsp I切割位点,使得能够直接通过聚合酶链反应/限制酶分析该突变。所有受影响家庭成员均显示为apo A-IFin突变的杂合子。等电聚焦显示受影响受试者的血清和HDL中均存在突变的apo A-IFin蛋白。通过在COS-7细胞中表达突变型和野生型apo A-I cDNA来检测该突变的功能后果。突变型apo A-I mRNA的大小与正常mRNA相似,突变型和野生型apo A-I蛋白均分泌到细胞培养基中。对apo A-I的体内动力学研究表明,受影响受试者的分解代谢增加。总之,我们描述了一种apo A-I基因的新型点突变,即apo A-IFin,它在血清HDL水平方面导致显性负性表型,可能是由于apo A-I的分解代谢增加所致。

相似文献

1
Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene.载脂蛋白A-I芬兰型。由于载脂蛋白A-I基因中的单个碱基替换导致的显性遗传性低α脂蛋白血症。
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):83-90. doi: 10.1161/01.atv.17.1.83.
2
Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.载脂蛋白A-IFIN(Leu159→Arg)突变影响卵磷脂胆固醇酰基转移酶的激活以及高密度脂蛋白的亚类分布,但不影响成纤维细胞的胆固醇流出。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3021-32. doi: 10.1161/01.atv.17.11.3021.
3
Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease.
Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1242-7. doi: 10.1161/01.atv.18.8.1242.
4
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.伴有黄瘤的高密度脂蛋白缺乏症。由载脂蛋白A-I基因点突变导致的逆向胆固醇转运缺陷。
J Clin Invest. 1993 Nov;92(5):2262-73. doi: 10.1172/JCI116830.
5
Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.与异常载脂蛋白E1表型和ε1/“无”基因型相关的重度III型高脂蛋白血症。
Eur J Clin Invest. 1992 Sep;22(9):599-608. doi: 10.1111/j.1365-2362.1992.tb01511.x.
6
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.载脂蛋白A-I中第151位残基的精氨酸被半胱氨酸取代后产生的表型与载脂蛋白A-米兰型相似。
Atherosclerosis. 1997 Jan 3;128(1):121-8. doi: 10.1016/s0021-9150(96)05982-5.
7
Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia.低α脂蛋白血症中载脂蛋白A-I、卵磷脂胆固醇酰基转移酶和葡萄糖脑苷脂酶基因的分析
Atherosclerosis. 2002 Jul;163(1):49-58. doi: 10.1016/s0021-9150(01)00753-5.
8
Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
Circulation. 1996 Oct 1;94(7):1622-8. doi: 10.1161/01.cir.94.7.1622.
9
Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.人群中因载脂蛋白A-I基因突变导致低α脂蛋白血症的频繁发生:一项基于人群的调查。
Hum Mol Genet. 1999 Feb;8(2):331-6. doi: 10.1093/hmg/8.2.331.
10
Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.法裔加拿大人群中的严重家族性高密度脂蛋白缺乏症。临床、生化及分子特征分析。
Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1015-24. doi: 10.1161/01.atv.15.8.1015.

引用本文的文献

1
Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins.载脂蛋白、ABCA1和LCAT在正常及异常高密度脂蛋白生物合成中的作用。
J Biomed Res. 2017 Nov 4;31(6):471-85. doi: 10.7555/JBR.31.20160082.
2
Structural Insights into High Density Lipoprotein: Old Models and New Facts.高密度脂蛋白的结构洞察:旧模型与新事实
Front Pharmacol. 2016 Jan 12;6:318. doi: 10.3389/fphar.2015.00318. eCollection 2015.
3
apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
载脂蛋白E3[K146N/R147W]作为一种显性负性载脂蛋白E形式,可阻止残余物清除并抑制高密度脂蛋白的生物合成。
J Lipid Res. 2014 Jul;55(7):1310-23. doi: 10.1194/jlr.M048348. Epub 2014 Apr 28.
4
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.载脂蛋白 A-IV 通过 ABCA1 和 LCAT 的参与促进载脂蛋白 A-IV 包含的高密度脂蛋白颗粒的生物发生。
J Lipid Res. 2013 Jan;54(1):107-15. doi: 10.1194/jlr.M030114. Epub 2012 Nov 6.
5
Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.含有L159R载脂蛋白A-I的功能失调高密度脂蛋白会导致高脂血症小鼠动脉粥样硬化加剧。
Biochim Biophys Acta. 2012 Mar;1821(3):502-12. doi: 10.1016/j.bbalip.2011.08.019. Epub 2011 Sep 14.
6
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.载脂蛋白 A-I 第 89 位到第 99 位域中负电荷残基的改变影响脂质稳态和 HDL 的成熟。
J Lipid Res. 2011 Jul;52(7):1363-72. doi: 10.1194/jlr.M012989. Epub 2011 Apr 19.
7
Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.载脂蛋白 E4 中的 R142C 取代导致的 III 型高脂蛋白血症的显性形式的分子病因。
J Lipid Res. 2011 Jan;52(1):45-56. doi: 10.1194/jlr.M008409. Epub 2010 Sep 22.
8
Plant sterols: factors affecting their efficacy and safety as functional food ingredients.植物甾醇:影响其作为功能性食品成分的功效与安全性的因素。
Lipids Health Dis. 2004 Apr 7;3:5. doi: 10.1186/1476-511X-3-5.